What is the recommended nicardipine infusion dose in micrograms per kilogram per minute for adults and pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nicardipine Dosing in Micrograms per Kilogram per Minute

Nicardipine is NOT dosed in micrograms per kilogram per minute in adults—it is dosed as a fixed mg/hour infusion starting at 5 mg/hour and titrated up to a maximum of 15 mg/hour. In pediatric patients, weight-based dosing of 0.5-3 micrograms/kg/minute is used.

Adult Dosing (Fixed mg/hour)

The American Heart Association/American Stroke Association guidelines consistently recommend nicardipine as a fixed-dose infusion for acute blood pressure management 1, 2, 3, 1:

  • Initial dose: 5 mg/hour IV infusion
  • Titration: Increase by 2.5 mg/hour every 5-15 minutes as needed
  • Maximum dose: 15 mg/hour
  • Maintenance: Once target blood pressure is achieved, reduce to 3 mg/hour 2

This dosing applies across multiple clinical scenarios including acute ischemic stroke (both thrombolytic-eligible and non-eligible patients) and hypertensive emergencies 1, 2, 3, 1. The 2018 ACC/AHA hypertension guidelines similarly recommend this fixed mg/hour dosing approach 4.

Important caveat: Adult dosing is NOT weight-based. The fixed mg/hour approach allows for predictable titration and avoids the complexity of weight-based calculations in emergency situations.

Pediatric Dosing (Weight-Based mcg/kg/min)

In contrast to adults, pediatric patients require weight-based dosing in micrograms per kilogram per minute:

Evidence-Based Pediatric Dosing:

  • Initial dose: 0.5-1 microgram/kg/minute 5, 6, 7
  • Effective dose range: 0.3-4 micrograms/kg/minute 5
  • Mean effective dose: 1.8 ± 1.0 microgram/kg/minute 5
  • Typical maintenance: 2.5-5.5 micrograms/kg/minute 8

Pediatric Titration Approach:

Start at 1 microgram/kg/minute and titrate upward as needed to achieve blood pressure control 5, 6, 7. In a study of 29 children with severe hypertension, blood pressure control was achieved within 2.7 ± 2.1 hours, producing a 16% reduction in systolic and 23% reduction in diastolic blood pressure 5.

Critical safety point: Nicardipine should be administered through a central line when possible in pediatric patients, as peripheral administration carries risk of superficial thrombophlebitis 6.

Clinical Context and Monitoring

Adult Hypertensive Emergencies:

The goal is typically a 10-15% reduction in blood pressure 1, 3, 1. In acute ischemic stroke patients eligible for thrombolysis, maintain systolic BP <185 mm Hg and diastolic <110 mm Hg 1, 2, 1.

Pediatric Intensive Care:

Target systolic BP <90 mm Hg in children under 4 years and ≤110 mm Hg in children ≥5 years 8. Blood pressure control is typically achieved within 15 minutes in most pediatric patients 8.

Monitoring Requirements:

  • Blood pressure every 15 minutes during initial titration
  • Continuous cardiac monitoring recommended
  • Watch for tachycardia (7% increase in heart rate is typical) 5
  • Monitor for hypotension, flushing, and palpitations 5

Key distinction: The fundamental difference between adult and pediatric nicardipine dosing reflects different pharmacokinetic considerations and the need for more precise weight-based dosing in children, whereas the fixed mg/hour approach in adults provides adequate blood pressure control with simpler administration.

References

Research

Nicardipine is a safe and effective agent in pediatric hypertensive emergencies.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000

Research

Intravenous nicardipine in hypertensive children.

European journal of pediatrics, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.